- Home
- FOLD vs LU Comparison
FOLD vs LU Comparison
Compare FOLD & LU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- LU
- Stock Information
- Founded
- FOLD 2002
- LU 2005
- Country
- FOLD United States
- LU China
- Employees
- FOLD N/A
- LU N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- LU Finance: Consumer Services
- Sector
- FOLD Health Care
- LU Finance
- Exchange
- FOLD Nasdaq
- LU Nasdaq
- Market Cap
- FOLD 2.5B
- LU 2.8B
- IPO Year
- FOLD 2007
- LU 2020
- Fundamental
- Price
- FOLD $9.41
- LU $2.74
- Analyst Decision
- FOLD Buy
- LU
- Analyst Count
- FOLD 7
- LU 0
- Target Price
- FOLD $30.29
- LU N/A
- AVG Volume (30 Days)
- FOLD 5.0M
- LU 2.7M
- Earning Date
- FOLD 11-04-2025
- LU 10-21-2025
- Dividend Yield
- FOLD N/A
- LU N/A
- EPS Growth
- FOLD N/A
- LU N/A
- EPS
- FOLD N/A
- LU N/A
- Revenue
- FOLD $598,704,000.00
- LU $4,671,260,668.00
- Revenue This Year
- FOLD $21.12
- LU N/A
- Revenue Next Year
- FOLD $21.23
- LU N/A
- P/E Ratio
- FOLD N/A
- LU N/A
- Revenue Growth
- FOLD 21.28
- LU N/A
- 52 Week Low
- FOLD $5.51
- LU $2.22
- 52 Week High
- FOLD $10.83
- LU $4.57
- Technical
- Relative Strength Index (RSI)
- FOLD 67.64
- LU 35.89
- Support Level
- FOLD $8.69
- LU $2.74
- Resistance Level
- FOLD $9.64
- LU $2.90
- Average True Range (ATR)
- FOLD 0.38
- LU 0.16
- MACD
- FOLD 0.03
- LU -0.02
- Stochastic Oscillator
- FOLD 82.68
- LU 2.10
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
About LU Lufax Holding Ltd each representing two (2)
Lufax Holding Ltd is a technology-empowered personal financial services platform in China. The company address the large unmet demand for personal lending among small business owners as well as salaried workers in China and provides tailor-made wealth management solutions to China's middle class and affluent population. Its platform has two hubs namely Retail Credit Facilitation Hub and Wealth Management Hub.